REFERENCES
- Allon N., Raveh L., Gilat E., Cohen E., Grunwald J., Ashani Y.. 1998. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Toxicol. Sci.. 43: 121–128. [PUBMED], [INFOTRIEVE], [CSA]
- Ashani Y., Shapira S., Levy D., Wolfe A. D., Doctor B. P., Raveh L.. 1991. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol.. 41: 37–41. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Benschop H. P., de, Jong L. P. A., Langenberg J. P.. 1995. Inhalation toxicokinetics of C(±)P(±)-soman and (±)-sarin in the guinea-pigs. Enzymes of the cholinesterase family, D. M., Quinn, A. S., Balasubramanian, B. P., Doctor, P., Taylor, pp. 361–368, New York, Plenum
- Brandeis R., Raveh L., Grynwald J., Cohen E., Ashani Y.. 1993. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol. Biochem. Behav.. 46: 889–896. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Broomfield C. A., Maxwell D. M., Solana R. P., Castro C. A., Finger A. V., Le D. E.. 1991. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J. Pharmacol. Exp. Ther.. 259: 633–638. [PUBMED], [INFOTRIEVE], [CSA]
- Doctor B. P., Blick D. W., Caranto G., Castro C. A., Gentry M. K., Larrison R., Maxwell D. M., Murphy M. R., Schutz M., Waibel K.. 1993. Cholinesterases as scavangers for organophosphorus compounds: Protection of primate performance against soman toxicity. Chem. Biol. Interact.. 87: 285–293. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Doctor B. P., Maxwell D. M., Ashani Y., Saxena A., Gordon R. K.. 2001; New approaches to Medical protection against chemical warfare nerve agents, Chemical warfare agents: Toxicity at low levels, S. M., Somani, J. A., Romano, Jr., pp. 191–214, New York, CRC Press
- Ellman G. L., Courtney D. K., Andres V., Featherstone R. M.. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol.. 7: 88–95. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kassa J.. 2002. The influence of anticholinergic drug and oxime selection on the effectiveness of antidotal treatment against tabun-induced poisoning in mice. Acta Med. (Hradec Králové). 45: 75–78. [CSA]
- Kassa J., Vachek J.. 2002. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology. 177: 179–185. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kuća K., Bielavský J., Cabal J., Bielavská M.. 2003. Synthesis of a potential reactivator of acetylcholinesterase1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett.. 44: 3123–3125. [CROSSREF], [CSA]
- Marrs T. C., Maynard R. L., Sidell F. R., 1996; Chemical warfare agents: Toxicology and treatment. New York, John Wiley and Sons
- Maxwell D. M.. 1992. The specifity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol.. 114: 306–312. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maxwell D. M., Brecht K. M.. 1991. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci. Biobehav. Rev.. 15: 135–139. [PUBMED], [INFOTRIEVE], [CSA]
- Maxwell D. M., Brecht K. M., Lenz D. E., O'Neill B. L.. 1988. Effect of carboxyleterase inhibition on carbamate protection against soman toicity. J. Pharmacol. Exp. Ther.. 246: 986–991. [PUBMED], [INFOTRIEVE], [CSA]
- Maxwell D. M., Castro C. A., De La, Hoz D. M., Genry M. K., Gold M. B., Solana R. P., Wolfe A., Doctor B. P.. 1992. Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase. Toxicol. Appl. Pharmacol.. 115: 44–49. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maxwell D. M., Brecht K. M., Doctor B. P., Wolfe A. D.. 1993. Comparison of antidote protection against soman by pyridostigmine, HI-6, and acetylcholinesterase. J. Pharmacol. Exp. Ther.. 264: 1085–1089. [PUBMED], [INFOTRIEVE], [CSA]
- Minami M., Hui D. M., Wang Z., Katsumata M., Inagaki H., Li Q., Inuzuka S., Mashiko K., Yamamoto Y., Ootsuka T., Boulet C. A., Clement J. G.. 1998. Biological monitoring of metabolites of sarin and its by-products in human urine samples. J. Toxicol. Sci.. 23: 250–254. [PUBMED], [INFOTRIEVE], [CSA]
- Polhuijs M., Langenberg J. P., Benschop H. P.. 1997. New method for retrospective detection of exposure to organophosphorus anticholinesterases: Application to alleged sarin victims of japanese terrorists. Toxicol. Appl. Pharmacol.. 146: 156–161. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Raveh L., Segall Y., Leader H., Rotschild N., Levanon D., Henis Y., Ashani Y.. 1992. Protection against tabun toxicity in mice by rophylaxis with an enzyme hydrolyzing organophosphate esters. Biochem. Pharmacol.. 44: 397–400. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Raveh L., Grunwald J., Marcus D., Papier Y., Cohen E., Ashani Y.. 1993. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. Biochem. Pharmacol.. 45: 2465–2474. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Raveh L., Grauer E., Grunwald J., Cohen E., Ashani Y.. 1997. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol. Appl. Pharmacol.. 145: 43–53. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ševelová L., Vachek J., Bajgar J.. 2003. Inhalation apparatus for generating sarin and soman vapors. Acta Med. (Hradec Králové). 46: 157–161. [CSA]
- Shih T. M., McDounagh J. H.. 1999. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol. Biochem. Behav.. 64: 147–153. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Van, Helden H. P. M., Trap H. C., Oostdijk J. P., Kuijpers W. C., Langenbeg J. P., Benschop H. P.. 2003. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: Lowest observable effec level. Toxicol. Appl. Pharmacol.. 189: 170–179. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wolfe A. D., Rush R. S., Doctor B. P., Koplovitz I., Jones D.. 1987. Acetylcholinesterase prophylaxis against organosphate toxicity. Fundam. Appl. Toxicol.. 9: 266–270. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wolfe A. D., Blick D. W., Murphy M. R., Miller S. A., Gentry M. K., Hartgraves S. L., Doctor B. P.. 1992. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol.. 117: 189–193. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]